Biotech

Throwing in more towels, and that’s very good

By GREGORY ZELLER // Another week, another significant partnership for Applied DNA Sciences, which continues to make itself at home in the national textiles market. The Stony Brook-based provider of DNA-focused supply chain, anti-counterfeiting and anti-theft technologies has signed a multi-year licensing agreement with Loftex Home LLC, a well-known maker of high-quality towels and other home textiles. The new deal builds upon a prior agreement between Applied DNA and New York City-based Loftex Home, announced…

Read More

Applied DNA goes ‘Beyond’ in cotton quest

By GREGORY ZELLER // Applied DNA Sciences is going to Bed Bath & Beyond, but not because it needs new towels. Instead, the Stony Brook-based provider of DNA-focused supply chain, anti-counterfeiting and anti-theft technologies, as well as product-genotyping and product-authentication solutions, is incorporating its “textile molecular tag” technology into the national retailer’s Wamsutta line – cotton products that claim to be made exclusively from pure Pima cotton grown in California. Now, thanks to Applied DNA’s…


With unique tech, Applied DNA gets into in vitro

By GREGORY ZELLER // A Stony Brook-based biotech has embarked on a five-year mission to safeguard in vitro diagnostics. In vitro studies, sometimes called “test tube experiments,” involve microorganisms, cells and other biological molecules outside their normal biological context. In the molecular biology era, such tests – performed not only in test tubes but in flasks, petri dishes and other laboratory vessels – have increased in both frequency and importance. Now, Applied DNA Sciences –…


In protein interactions, it’s the little things that count

Fair warning to the protein complexes behind some of planet Earth’s most nefarious diseases, which have hid from mainstream researchers through decades of molecular science: Stony Brook University is coming for you. An SBU-led research team has created an automated computer server that calculates complex computations for modeling protein interactions. If that sounds like thick science, it is: Aside from water, proteins are the most abundant substance in living cells, and modeling their interactions with cellular…


Financing set, cannabinoid-concussion study aims high

By GREGORY ZELLER // And now, onto the science. Canadian mining exploration company Kitrinor Metals Inc. and Scythian Biosciences Inc., a Calgary-based biotech owned by Great Neck investment banker Jonathan Gilbert, have announced a pair of deals that complete first-round financing for Scythian, which is exploring cannabinoid-based treatments for concussions. The new deals add on to the $13.08 million (Canadian) in brokered financing, led by Ontario-based Clarus Securities Inc., already raised by Scythian Biosciences, which…


At Applied DNA, they’re really getting into leather

By GREGORY ZELLER // A new international partnership backed by a host of well-known global brands will develop DNA-based security and product-authentication solutions for the leather industries. Stony Brook-based biotech Applied DNA Sciences this week announced a “research agreement” with BLC Leather Technology Centre, a UK-based R&D firm that delivers a range of services to leather suppliers, manufacturers and distributors in some 40 countries. Applied DNA President and CEO James Hayward introduced the program March 30 at…


Stock deal locks funds for Scythian marijuana study

By GREGORY ZELLER // A Canadian R&D firm with Long Island roots has locked up the first tranche of a strategic investment that will fund a major study involving concussions and medical marijuana. Scythian Biosciences Inc. and Canadian mining exploration company Kitrinor Metals Inc. on Tuesday announced a “brokered private placement” that gives 32.7 million common shares of Calgary-based Scythian, owned by Great Neck investment banker Jonathan Gilbert, to an investment team including lead agent…